Business Intelligence

Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.

Imaging Costs Not A Major Component of Wasted Health Care Expenditures

Unnecessary tests and treatments cost the U.S. health care system $6.7 billion in 2009, but expenditures for unnecessary imaging dwarfed those for other procedures, according to a research letter published in the October 1 edition of Archives of Internal Medicine.

Supercommittee Stalemate Might Be Best for Radiology

Cindy Moran, a former Republican Senate staffer who now lobbies for the American College of Radiology (ACR), doesn't mince words when it comes to the prospect of the Congressional supercommittee recommending using health care cuts to reduce the nation's budget deficit by at least $1.2 trillion in the next 10 years.

Sutter's California Pacific Medical Center Acquires Fusion Diagnostic Group

San Francisco outpatient diagnostic imaging provider Fusion Diagnostic Group LLC has been purchased by the California Pacific Medical Center, part of the not-for-profit Northern California healthcare network Sutter Health.

Specialty Physicians May Benefit From Rising Health Care Costs, Study Says

Rising health care costs and health care reform—particularly the creation of health insurance exchanges (HIEs)--may actually benefit, rather than hurt, 10 health care sub-segments.

Groups Seek to Scrap Medicare Advisory Panel

Twenty medical specialty groups today urged the Congressional Supercommittee to scrap the controversial Medicare payment advisory panel (IPAB) established under health care reform law.

Supreme Court Hears Medicaid Case

Lawyers for California and the federal government today urged the U.S. Supreme Court not to allow patients and doctors to initiating lawsuits over cuts to Medicaid payments.

FDA Issues Guidance on Low- to Moderate-Risk Devices

The U.S. Food and Drug Administration (FDA) has announced that it has issued for manufacturers a draft guidance that updates and streamlines the evaluation of automatic class III designation, the de novo review process used for certain innovative, low- to moderate-risk medical devices that do not meet the requirements for clearance under the 510(k)

ASTRO, NRC Uninterested in Creating Punitive Radiation Oncology Environment

The culture of radiation therapy may be changing, but neither the American Society for Radiation Oncology (ASTRO) nor the U.S. Nuclear Regulatory Commission (NRC), the primary federal agency responsible for regulating many technologies used in radiation therapy, is interested in creating a punitive environment for radiation oncologists. Rather, the